Preclinical characterization of the novel anti-SIRPα antibody BR105 that targets the myeloid immune checkpoint.
J Immunother Cancer
; 10(3)2022 03.
Article
in En
| MEDLINE
| ID: mdl-35256517
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
CD47 Antigen
/
Neoplasms
Limits:
Animals
/
Humans
Language:
En
Journal:
J Immunother Cancer
Year:
2022
Type:
Article
Affiliation country:
China